Lupin 2024

generic version of Aromasin

Mylan releases Aromasin generic in U.S.

Mylan releases Aromasin generic in U.S.

PITTSBURGH — Mylan N.V. has launched exemestane tablets 25 mg, a breast cancer medication, in the United States. Mylan said its exemestane product is a generic version of Aromasin tablets from Pfizer Inc. Exemestane is indicated for the treatment of certain types of breast cancer in women after menopause. The medication works by reducing estrogen

Centrum 7/6  banner